Gentamicin
Report in 12 hours
Booked 0 times
Gentamicin

The Gentamicin Test: Assessing Antibiotic Sensitivity in Bacterial Cultures

The Ibn Sina Trust
Praava Health
Dr Lal PathLabs
Omnicare Diagnostic Limited
Thyrocare Bangladesh Ltd
Brac Healthcare
Popular Diagnostic Centre Ltd
JG Healthcare
Probe Bangladesh Limited
1120
1400
20% OFF
Sample Type
blood
Fasting Required
No
Description

The Gentamicin test is a laboratory procedure used to determine the susceptibility of bacteria to the antibiotic Gentamicin. It involves placing a paper disk containing a known concentration of Gentamicin onto a culture plate inoculated with the bacteria of interest. After an incubation period, the diameter of the zone of inhibition around the disk is measured. A larger zone of inhibition indicates that the bacteria are susceptible to Gentamicin, while a smaller zone or no zone indicates resistance.

Covid Safety

Assured

Free Report

Counselling

How our test process works!

Step 1

Sample Collection

Vaccinated Phlebotomists collects from syringe in the barcoded vials

Step 2

Sample Storage

Only vaccinated phelbos are assigned orders

Step 3

High Tech Facility

Lab ingests the sample into processing machines which are 100% automated

Step 4

Accurate Digital Reports

The reports are generated by the processing machines and clinically correlated by doctors

Overview

Overview

Purpose:

  • To monitor gentamicin levels in the blood to ensure they are within a therapeutic range, avoiding potential toxicity while ensuring effective treatment.

Procedure:

  1. Timing of Sample Collection: Blood samples are usually collected at specific times, often just before the next dose (trough level) and/or shortly after the dose (peak level), depending on the clinical situation and monitoring protocol.
  2. Test: The concentration of gentamicin in the blood is measured using various laboratory techniques.
Risk Assessment

Risk Assessment

  • Kidney Function: Gentamicin can be nephrotoxic. Monitoring is crucial for patients with pre-existing kidney conditions or those on prolonged therapy.
  • Hearing Impairment: It can also be ototoxic, affecting hearing, especially at high levels or with prolonged use.
  • Dosage Adjustment: For patients with impaired renal function or those receiving high doses, more frequent monitoring may be required to adjust dosages and prevent toxicity.
Normal Range

Normal Range

  • Peak Level: Typically measured 30 minutes to 1 hour after an intravenous dose.
    • Therapeutic Range: Generally 5-10 µg/mL (micrograms per milliliter), but this can vary based on the infection being treated.
  • Trough Level: Typically measured just before the next dose.
    • Therapeutic Range: Generally less than 1-2 µg/mL. Levels higher than this can increase the risk of toxicity.
Interpretation

Interpretation

  • Therapeutic Range:

    • Peak Levels: Within the therapeutic range indicates effective drug concentration for treating the infection.
    • Trough Levels: Within the therapeutic range indicates minimal risk of toxicity.
  • Subtherapeutic Levels: If the peak level is below the therapeutic range, the drug may not be effective in treating the infection. If the trough level is above the therapeutic range, there is an increased risk of toxicity.

  • Toxic Levels: High levels, particularly in the trough sample, may indicate potential nephrotoxicity (kidney damage) or ototoxicity (hearing damage). Symptoms of toxicity can include ringing in the ears, dizziness, and changes in kidney function.

Sample Type

Sample Type

  • Blood Sample: Typically, a venous blood sample is collected. For accurate assessment:
    • Peak Levels: Drawn 30 minutes to 1 hour after the completion of an intravenous dose.
    • Trough Levels: Drawn just before the next dose is due.

Frequently Asked Question